LAMPIRAN

Frequency Table

JENIS_KELAMIN

Frequency Percent Valid Percent Cumulative

Percent

Laki-laki 79 66,4 66,4 66,4

Valid Perempuan 40 33,6 33,6 100,0

Total 119 100,0 100,0

UMUR

Frequency Percent Valid Percent Cumulative

Percent

30 - 50 tahun 30 25,2 25,2 25,2

51 - 70 tahun 65 54,6 54,6 79,8

Valid
71 - 90 tahun 24 20,2 20,2 100,0

Total 119 100,0 100,0

NILAI_LDL

Frequency Percent Valid Percent Cumulative

Percent

Optimal (<100 mg/dl) 37 31,1 31,1 31,1

Mendekati Optimal (100 - 129 65 54,6 54,6 85,7

mg/dl)
Valid
Batas Tinggi (130 - 159 mg/dl) 15 12,6 12,6 98,3

Tinggi (160 - 189 mg/dl) 2 1,7 1,7 100,0

Total 119 100,0 100,0

ACS

Frequency Percent Valid Percent Cumulative

Percent

APTS 55 46,2 46,2 46,2

NSTEMI 28 23,5 23,5 69,7

Valid
STEMI 36 30,3 30,3 100,0

Total 119 100,0 100,0

Bar Chart
 NILAI_LDL * ACS Crosstabulation

ACS Total

APTS NSTEMI STEMI

Count 19 9 9 37
Optimal (<100 mg/dl) Expected Count 17,1 8,7 11,2 37,0

% of Total 16,0% 7,6% 7,6% 31,1%

Count 31 12 22 65

Mendekati Optimal (100 - 129 mg/dl) Expected Count 30,0 15,3 19,7 65,0

% of Total 26,1% 10,1% 18,5% 54,6%

NILAI_LDL
Count 4 6 5 15

Batas Tinggi (130 - 159 mg/dl) Expected Count 6,9 3,5 4,5 15,0

% of Total 3,4% 5,0% 4,2% 12,6%

Count 1 1 0 2

Tinggi (160 - 189 mg/dl) Expected Count ,9 ,5 ,6 2,0

% of Total 0,8% 0,8% 0,0% 1,7%

Count 55 28 36 119

Total Expected Count 55,0 28,0 36,0 119,0

% of Total 46,2% 23,5% 30,3% 100,0%
 Chi-Square Tests

Value df Asymp. Sig. (2-

sided)

Pearson Chi-Square 5,892a 6 ,435

Likelihood Ratio 6,341 6 ,386
Linear-by-Linear Association ,879 1 ,349
N of Valid Cases 119

a. 5 cells (41,7%) have expected count less than 5. The minimum expected count
is ,47.

Risk Estimate

Value
a
Odds Ratio for NILAI_LDL
(Optimal (<100 mg/dl) /
Mendekati Optimal (100 - 129
mg/dl))

a. Risk Estimate statistics cannot be

computed. They are only computed for a 2*2
table without empty cells.

Descriptives

Statistic Std. Error

Mean 1,84 ,079

95% Confidence Interval for Lower Bound 1,68

Mean Upper Bound 2,00

5% Trimmed Mean 1,82

Median 2,00

Variance ,745

ACS Std. Deviation ,863

Minimum 1

Maximum 3

Range 2

Interquartile Range 2

Skewness ,316 ,222

Kurtosis -1,593 ,440

Mean 1,85 ,064

NILAI_LDL 95% Confidence Interval for Lower Bound 1,72

Mean Upper Bound 1,98
 5% Trimmed Mean 1,81

Median 2,00

Variance ,485

Std. Deviation ,697

Minimum 1

Maximum 4

Range 3

Interquartile Range 1

Skewness ,520 ,222

Kurtosis ,268 ,440

Tests of Normality

Kolmogorov-Smirnova Shapiro-Wilk

Statistic df Sig. Statistic df Sig.

ACS ,297 119 ,000 ,753 119 ,000

NILAI_LDL ,275 119 ,000 ,801 119 ,000

a. Lilliefors Significance Correction

Kruskal-Wallis Test

Ranks

ACS N Mean Rank

APTS 55 56,17

NSTEMI 28 63,91
NILAI_LDL
STEMI 36 62,81

Total 119

Test Statisticsa,b

NILAI_LDL

Chi-Square 1,584
df 2
Asymp. Sig. ,453

a. Kruskal Wallis Test

b. Grouping Variable: ACS